NYSE:SENS

Senseonics Stock Insider Trading

Healthcare > Medical - Devices

Buy SENS

*Your capital is at risk

$6.36

-0.380 (-5.64%)

At Close: Jun 22, 2026

Senseonics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 92.80. In total, the insiders bought 11.5M and sold 652.83K SENS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	92.80
● Buy	11.5M shares
● Sell	652.83K shares
74% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence Jun 15, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 92.8. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 15, 2026 Sell	Common Stock F-InKind	Kaufman Francine Chief Medical Officer	Officer	4 010 Value: $28.8K
Jun 15, 2026 Sell	Common Stock F-InKind	Jain Mukul Chief Operating Officer	C-Suite Officer	16 194 Value: $116.3K
Jun 15, 2026 Sell	Common Stock F-InKind	Sullivan Frederick T. Chief Financial Officer	C-Suite Officer	5 397 Value: $38.8K
Jun 15, 2026 Sell	Common Stock F-InKind	Horton Kenneth L GC & Corp. Development Advisor	Officer	9 545 Value: $68.5K
Jun 15, 2026 Sell	Common Stock F-InKind	Hansen Brian B Chief Commercial Officer	Officer	5 420 Value: $38.9K
Jun 15, 2026 Sell	Common Stock F-InKind	Goodnow Timothy T President And CEO	CEO / President	32 598 Value: $234.1K
May 20, 2026 Buy	Stock Option (right to buy) A-Award	Roeder Douglas A Director	Director	13 574 Value: $77.5K
May 20, 2026 Buy	Common Stock A-Award	Roeder Douglas A Director	Director	9 852 Value: $56.3K
May 20, 2026 Buy	Stock Option (right to buy) A-Award	Prince Douglas S Director	Director	13 574 Value: $77.5K
May 20, 2026 Buy	Common Stock A-Award	Prince Douglas S Director	Director	9 852 Value: $56.3K
May 20, 2026 Buy	Stock Option (right to buy) A-Award	Larkin Sharon Director	Director	13 574 Value: $77.5K
May 20, 2026 Buy	Common Stock A-Award	Larkin Sharon Director	Director	9 852 Value: $56.3K
May 20, 2026 Buy	Stock Option (right to buy) A-Award	Fiorentino Edward Director	Director	13 574 Value: $77.5K
May 20, 2026 Buy	Common Stock A-Award	Fiorentino Edward Director	Director	9 852 Value: $56.3K
May 20, 2026 Buy	Stock Option (right to buy) A-Award	Steven Edelman Director	Director	13 574 Value: $77.5K
May 20, 2026 Buy	Common Stock A-Award	Steven Edelman Director	Director	9 852 Value: $56.3K
May 20, 2026 Buy	Stock Option (right to buy) A-Award	Defalco Stephen P Director	Director	13 574 Value: $77.5K
May 20, 2026 Buy	Common Stock A-Award	Defalco Stephen P Director	Director	9 852 Value: $56.3K
May 19, 2026 Buy	Employee Stock Option (right to buy) A-Award	Goodnow Timothy T President And CEO	CEO / President	761 923 Value: $4.22M
May 19, 2026 Buy	Common Stock A-Award	Goodnow Timothy T President And CEO	CEO / President	553 701 Value: $3.07M
May 19, 2026 Buy	Employee Stock Option (right to buy) A-Award	Hansen Brian B Chief Commercial Officer	Officer	124 193 Value: $688.0K
May 19, 2026 Buy	Common Stock A-Award	Hansen Brian B Chief Commercial Officer	Officer	90 253 Value: $500.0K
May 19, 2026 Buy	Employee Stock Option (right to buy) A-Award	Sullivan Frederick T. Chief Financial Officer	C-Suite Officer	124 193 Value: $688.0K
May 19, 2026 Buy	Common Stock A-Award	Sullivan Frederick T. Chief Financial Officer	C-Suite Officer	90 253 Value: $500.0K
May 19, 2026 Buy	Employee Stock Option (right to buy) A-Award	Jain Mukul Chief Operating Officer	C-Suite Officer	372 579 Value: $2.06M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SENSEONICS HOLDINGS INC

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a conven...

Read Full Profile Here